Kanagawa, Japan

Morihisa Saitoh

USPTO Granted Patents = 10 


 

Average Co-Inventor Count = 8.0

ph-index = 3

Forward Citations = 26(Granted Patents)


Location History:

  • Osaka, JP (2013)
  • Kanagawa, JP (2015 - 2020)
  • Fujisawa, JP (2020)
  • Fujisawa Kanagawa, JP (2021 - 2023)

Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Morihisa Saitoh: Innovator in Cyclic Dinucleotide Research

Introduction

Morihisa Saitoh is a prominent inventor based in Kanagawa, Japan, known for his significant contributions to the field of biochemistry, particularly in the development of compounds with STING agonistic activity. With a portfolio of 10 patents to his name, Saitoh is at the forefront of research that has implications for the prophylaxis and treatment of STING-related diseases.

Latest Patents

Among Saitoh's latest patents are groundbreaking inventions focused on cyclic dinucleotides. His work includes:

1. **Methods of making a cyclic dinucleotide** - This patent discloses a compound that exhibits STING agonistic activity, aiming to provide new avenues for treating STING-related diseases. The compound is represented by a specific formula, highlighting its potential as a therapeutic agent.

2. **Antibody-drug conjugates comprising a cyclic dinucleotide** - Similar to his previous patent, this invention also outlines a compound with STING agonistic properties, again indicating its potential for treating diseases associated with the STING pathway, with the details specified by a defined formula.

Career Highlights

Morihisa Saitoh currently works at Takeda Pharmaceutical Company Limited, a leading global pharmaceutical company focused on research and development. His innovative work in the biotechnology sector has positioned him as a crucial figure in the pursuit of novel therapeutic strategies.

Collaborations

Throughout his career, Saitoh has collaborated with esteemed colleagues, including Yasufumi Wada and Masato Yoshikawa. These partnerships have enhanced the innovation and research capabilities within his projects, helping advance the understanding and application of cyclic dinucleotides in medicine.

Conclusion

Morihisa Saitoh stands out as a dedicated inventor whose work has the potential to make a significant impact on the treatment of various diseases. With his innovative approaches and collaborations at Takeda Pharmaceutical Company Limited, Saitoh continues to contribute to the advancement of medical science through his patents and research efforts. His achievements in the field underline the importance of innovation in addressing health challenges faced by society today.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…